According to West Virginia Attorney General Patrick Morrisey, a $17 million settlement between the state, Pfizer, and Ranbaxy has been approved. The antitrust lawsuit involved a generic, cheaper ...

Pfizer’s monopoly over the blockbuster cholesterol-reducing molecule atorvastatin, trade name Lipitor, ends today (November 30) with the expiration of the patent that has brought the company over $100 ...

In the United States, Pfizer’s revenue was further hit by the loss of exclusivity of high chlorestorol medication, Lipitor (atorvastatin calcium), when its patent ran out in November 2011.

Pfizer lost its patent on the cholesterol-lowering drug Lipitor on November 30 -- which spells big savings for many of the 8.7 million Americans who take the medication. The patent’s expiration ...

Pfizer is famous for having marketed Lipitor, the cholesterol lowering statin drug that became the world's biggest selling drug before going off patent in 2011. The firm is now looking to pioneer ...

It alleged that Pfizer Inc. and Ranbaxy Inc. delayed the production of a cheaper version of the cholesterol-lowering drug Lipitor. West Virginia received a total of $3,485,000 from the settlement.

After 11 years of development and barely one full year of sales, New York–based Pfizer dumped the much-anticipated inhaled powder insulin product Exubera on 18 October. This was particularly bad ...

In December 2006, when Pfizer reported the mortality of cardiovascular patients in a phase 3 trial receiving torcetrapib and atorvastatin was greater than that of patients receiving atorvastatin ...

Pfizer is known for making blockbuster drugs Viagra and Lipitor. Here's the story of how Allergan went from a small Los Angeles company known for making eye-drops to an Ireland-domiciled drug ...